Program Information
The American College of Rheumatology will host the Reproductive Health in Rheumatic Disease Symposium on May 20th, 2022. This half-day virtual event seeks to connect rheumatology leaders and experts to share innovative approaches to managing patients, as well as ongoing research and available resources =in reproductive health and rheumatic disease.
Sessions will focus on advancing the 2020 American College of Rheumatology Guidelines for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases, current research in special contexts and case studies, COVID and reproductive health in rheumatic disease, and roundtable discussions about next steps in the field.
Attendees will have on-demand access to all sessions for 6 months after the event.
Attendees: Please submit your bio for the virtual platform to COIN@rheumatology.org
Click Here to Download the Required Template
Download Full Agenda HereTarget Audience
This event will bring together rheumatology professionals and other specialists who are engaged in reproductive health and rheumatic disease work. Invited attendees include rheumatologists, reproductive health experts, clinical researchers, and patient advocates.
Learning Objectives
Coming soon!
Program Schedule
| 12pm – 12:15pm EST |
Opening RemarksMichael Battistone, MD
Douglas White, MD, PhD |
| 12:15pm – 12:45pm EST |
Keynote Address – The State of Reproductive Health in RheumatologyMegan Clowse, MD, MPH
Moderator: Michael D. Lockshin, MD |
| 12:45pm – 1:45pm EST |
General Session – Advancing the GuidelinesMehret Talabi, MD, PhD
Lisa Sammaritano, MD
Moderator: Arthur Kavanaugh, MD |
| 1:45pm – 2:00pm EST |
Breakout Session Transition |
| 2:00pm – 3:00pm EST |
Breakout Session 1: Current Research & CasesBreakout Session 1A: Current research & cases in LupusEvelyne Vinet, MD
Mary Mahieu, MD
Moderator: Jill Buyon, MD
Breakout Session 1B: Current research & cases in pre-conception counseling, fertility preservation, and male reproductive healthWendy Marder, MD
Arthur Kavanaugh, MD
Adegbenga Bankole, MD, FACR
Moderator: Chelsey Smith, MD
Breakout Session 1C: Current research & cases in inflammatory arthritisKristen Demoruelle, MD, PhD
Kelly Wise, PharmD
Joann Zell, MD
Moderator: Andrew Wong, MD
Breakout Session 1D: Current research & cases in adolescents & young adultsCuoghi Edens, MD, FAAP
Elise Berlan, MD, MPH, FAAP, FSAHM
Stacy Ardoin, MD
Moderator: Tova Ronis, MDCM |
| 3:00pm – 3:10pm EST |
Break |
| 3:10pm – 4:00pm EST |
General Session: COVID & Reproductive Health in Rheumatic DiseaseChristina Chambers, MPH, PhD
Philip Robinson, PhD
Moderator: Michael Battistone, MD |
| 4:00pm – 4:10pm EST |
Breakout Session Transition |
| 4:10pm – 5:10pm EST |
Breakout Session 2: Roundtable Discussions – Next StepsBreakout Session 2A: Research AgendaMegan Clowse, MD, MPH
Mehret Talabi, MD, PhD
Rosalind Ramsey-Goldman, MD, DrPH
Moderator: Jane Salmon, MD
Breakout Session 2B: Clinical PearlsKristen Demoruelle, MD, PhD
Cuoghi Edens, MD, FAAP
Moderator: Brittany Bettendorf, MD
Breakout Session 2C: Student and Trainee EducationMichael Battistone, MD
Bethany Marston, MD
Moderator: Whitney White, PharmD, BCPS, FASHP, FALSHP |
| 5:10pm – 5:30pm EST |
Closing Remarks |
Registration Fees
This event is free to attend for invited guests.
CME and MOC Information
CME and MOC are not available for this event.
Faculty and Disclosures
2022 disclosures coming soon.
Corporate Support
This educational opportunity was supported by a medical education grant from GlaxoSmithKline to address Systemic Lupus Erythematosus (SLE) and Reproductive Health education to support patients, educators, and clinical teams. Its contents are solely the responsibility of the speakers and do not necessarily reflect the official views of GlaxoSmithKline.
This project was supported by Grant number 1NU58DP006908-01-00 – Component A: Developing and Disseminating Programs to Build Sustainable Lupus Awareness, Knowledge, Skills and Partnerships. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Health and Human Services, Centers for Disease Control and Prevention.